pillbase.ru

Terlivaz

Active substance: terlipressin

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TERLIPRESSIN .85 mg/5mL

United StatesActive

Marketing holder: Mallinckrodt Hospital Products Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Реместип®
    раствор для внутривенного введения, 0.1 мг/мл, 10 мл (original in Russian, GRLS)
    П N013886/01
    Ферринг-Лечива а.с.
  • ТЕРЛИПРЕССИН МИРФАРМ
    раствор для инъекций, 1 мг, 10 мл (original in Russian, GRLS)
    ЛП-№(003436)-(РГ-RU)
    ООО "Лайф Сайнсес ОХФК"
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-548c-74a8-bd91-7cddb59c1899,01a120c4-2fcb-7bf7-a09b-3b1ad678bddd;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-b207-7a8a-9b48-f6ac61af6356;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
43825-200
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 43825-200 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 43825-200 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 43825-200 · Verified 2026-10-09 · open in source